Ehrlich ascites carcinoma
Open-knowledge reference entry
Ehrlich-Lettre ascites carcinoma (EAC) is also known as Ehrlich cell. It was originally established as an ascites tumor in mice.
Ehrlich cell
The tumor was cultured in vivo, which became known as the Ehrlich cell. After 1948 Ehrlich cultures spread around research institutes all over the world. The Ehrlich cell became popular because it could be expanded by in vivo passage. This made it useful for biochemical studies involving large amounts of tissues. It could also be maintained in vitro for more carefully controlled studies. Culture techniques in large-scale, mice passage is less attractive, due to the contamination of the tumor with multifarious host inflammatory cells.
Properties
EAC is referred to as undifferentiated carcinoma, and is originally hyper-diploid. The permeability to water is highest at the initiation of the S phase and progressively decreases to its lowest value just after mitosis.
The public source identifies “Ehrlich ascites carcinoma” as open-knowledge reference entry. This brief keeps that definition visible, then builds a research path around Ehrlich, ascites and carcinoma.
Why this record matters
A short description can identify a subject without explaining its stakes. For “Ehrlich ascites carcinoma”, the useful work is to connect “open-knowledge reference entry” to the records capable of establishing context and consequence.
Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Jun 2, 2023. The linked authority identifier is Q25326666. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1948.
The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Ehrlich ascites carcinoma”, its source revision and the description used here.
- Expand the search: follow Ehrlich ascites carcinoma primary sources, Ehrlich ascites carcinoma archive and Ehrlich research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Ehrlich ascites carcinoma”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Ehrlich ascites carcinoma” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.